Journals / Eurasian Journal of Medicine / 2019 / Cilt: 51 - Sayı: 1

Complete Heart Block due to Octreotide Infusion in Patient with Cryptogenic Cirrhosis

Pages
95–97
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

He was discharged upon recommendation.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:A 62-year-old man was admitted to the emergency department (ED) with the complaint of intense hematemesis.
📊
Key Findings & Data:He was admitted to intensive care unit because of acute esophageal variceal hemorrhage.
💡
Conclusion & Impact:He was discharged upon recommendation.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

A 62-year-old man was admitted to the emergency department (ED) with the complaint of intense hematemesis. He was admitted to intensive care unit because of acute esophageal variceal hemorrhage. He underwent sclerotherapy followed by a slow infusion of intravenous octreotide. Complete heart block occured in the patient during octreotide infusion and infusion was stopped. Temporary pacemaker was placed in the patient’s heart. Normal sinus rhythm was observed in the follow up one day later and the pacemaker was removed from patient. He was discharged upon recommendation.

🔖

Cite This Article

SÜMBÜL, H. E., İÇEN, Y. K., URGUN, O. D., KOÇ, M. (2022). Complete Heart Block due to Octreotide Infusion in Patient with Cryptogenic Cirrhosis. Eurasian Journal of Medicine, Cilt: 51 - Sayı: 1, 95–97. https://ajindex.com/articles/508962

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (4)

  1. Shah HA, Mumtaz K, Jafri W, et al. Sclerotherapy plus octreotide versus sclerotherapy alone in the management of gastro-oesophageal variceal hemorrhage. J Ayub Med Coll Abbottabad 2005; 17: 10-4
  2. Chanson P, Timsit J, Masquet C, et al. Cardiovascular effects of the somatostatin analog octreotide in acromegaly. Ann Intern Med 1990; 113: 921-5. [CrossRef] 3. Dilger JA, Rho EH, Que FG, Sprung J. Octreotide induced bradycardia and heart block during surgicalresection of a carcinoid tumor. Anesth Analg 2004; 98: 318-20. [CrossRef] 4. Sàbat M, Guarner C, Soriano G, et al. Effect of subcutaneous administration of octreotide on endogenous vasoactive systems and renal function in cirrhotic patients with ascites. Dig Dis Sci 1998; 43: 2184-9. [CrossRef] 5. Eriksson LS, Brundin T, Soderlund C, Wahren J. Haemodynamic effects of a long-acting somatostatin analogue in patients with liver cirrhosis. Scand J Gastroenterol 1987; 22: 919-25. [CrossRef] 6. Erbas T, Usman A, Erbas B, Varoglu E, Aras T, Bekdik C. Short-term effects of somatostatin analogue (SMS 201-995) on left ventricular function in healthy persons: a scintigraphic study. J Endocrinol Invest 1993; 16: 857-61. [CrossRef] 7. Baik SK, Jeong PH, Ji SW, et al. Acute hemodynamic effects of octreotide and terlipressin in patients with cirrhosis: a randomized comparison. Am J Gastroenterol 2005; 100: 631-5. [CrossRef] 8. McCormick PA, Chin J, Greenslade L, et al. Cardiovascular effects of octreotide in patients with hepatic cirrhosis. Hepatology 1995; 21: 1255-60. [CrossRef] 9. Katz MD, Erstad BL. Octreotide, a new somatostatin analogue. Clin Pharm 1989; 8: 255-73
  3. Herrington AM, George KW, Moulds CC. Octreotide-induced bradycardia. Pharmacotherapy 1998; 18: 413-6
  4. Tuncer M, Gümrükçüoğlu HA, Mete R, Güneş Y, Güntekin U. A case of complete heart block induced by octreotide. Turk J Gastroenterol 2010; 21: 72-3. [CrossRef]